AGITATION,PSYCHOMOTOR
Clinical trials for AGITATION,PSYCHOMOTOR explained in plain language.
Never miss a new study
Get alerted when new AGITATION,PSYCHOMOTOR trials appear
Sign up with your email to follow new studies for AGITATION,PSYCHOMOTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could cannabis calm Alzheimer's agitation? new trial underway
Symptom relief Recruiting nowThis study tests whether IGC-AD1, a THC-based oral medication, can safely reduce agitation in people with mild to severe Alzheimer's dementia. About 164 participants will receive either the drug or a placebo twice daily for several weeks. Researchers will measure changes in agita…
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: PHASE2 • Sponsor: IGC Pharma, LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Shock therapy for dementia agitation? new trial tests ECT
Symptom relief Recruiting nowThis study tests whether adding electroconvulsive therapy (ECT) to usual care can safely reduce severe agitation in people with moderate to severe dementia, including Alzheimer's and other types. Fifty participants will receive ECT sessions with anesthesia, and researchers will m…
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: NA • Sponsor: Brent Forester • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC